Last update 07 Sep 2023

ProLectin Rx

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ProLectin-A, ProLectin-I, ProLectin-M
+ [5]
Target
galectin-1(Galectin-1)
Mechanism
galectin-1 inhibitors(Galectin-1 inhibitors)
Therapeutic Areas
Infectious Diseases, Respiratory Diseases
Active Indication
COVID-19, Idiopathic Pulmonary Fibrosis
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Highest Phase (Global)Phase 3 Clinical
First Approval Date(Global)-
Regulation-

R&D Status

IndicationHighest PhaseCountry/LocationOrganization
COVID-19Phase 3 Clinical-
Idiopathic Pulmonary FibrosisPhase 1 ClinicalIN
More
Login to view more data

Clinical Trial Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
-
-
-
iwcrnzllrr = jjdycgmucb dwrcxrgjgu (vmsotbqann )
-
20 Jun 2006
iwcrnzllrr = kerpvembej dwrcxrgjgu (vmsotbqann )
Login to view more data

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial Analysis

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.